WallStreetReport.Net Is Issuing Mid Day Trend Analysis Reports for October 23rd, 2012: Organovo Holdings, Inc. (PINK:ONVO), Medical Marijuana, Inc (PINK:MJNA), OnoSec Medical Incorporated (OTC:ONCS), Hypersolar Inc. (OTC:HYSR)
New York, NY -- (ReleaseWire) -- 10/23/2012 --Organovo Holdings, Inc. (PINK:ONVO) is trading at $2.36 down by 6.72% on a volume of 332, 839. ONVO has been trading so far during the day between $2.31 and $2.58. It touched its highest price point early this morning around 9:30 AM. Today’s trading session has not been so good so far for the company as the stock keeps on dipping and there is no signs for it picking up steam so far.
In the last 52 weeks, ONVO has been trading between $1.24 and $10.90. The stock is trading below expectations and the only way to find out when could be a good moment to trade ONVO is by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=ONVO
Medical Marijuana, Inc (PINK:MJNA) is alerting at $0.0940 up by 5.62% compared to yesterday’s trading session and on a volume of 4,306,182 which is higher than the last 3 months average of 3,883,890. The stock has been trading so far between $0.0850 and $0.0990 and after a major drop very early today, MJNA looks like its back on track and has been gaining since then.
On October 22nd 2012, Medical Marijuana announced that its portfolio company, Red Dice Holdings, received national media attention for its Dixie Elixirs & Edibles brand on the 60 Minutes "Rocky Mountain High" segment this past Sunday, October 21.
Find out where MJNA could be heading by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=MJNA
OnoSec Medical Incorporated (OTC:ONCS) is losing 4.25% so far in today’s trading session alerting at $0.4280 on a volume of 2,207,383. ONCS could pick up lot more steam after the announcement today that the company reported positive preliminary efficacy and safety results from Phase 2 study of ImmunoPulse in Merkel cell carcinoma patients. Here is a direct link to the company’s announcement: http://finance.yahoo.com/news/oncosec-medical-incorporated-reports-positive-100700929.html
Upon reading this announcement, find out what could be the best move with ONCS by reading the FREE trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=ONCS
Hypersolar Inc. (OTC:HYSR) is amongst the biggest gainers so far in today’s trading session as the stock has been trading up by 25.00% at $0.02 on a volume of 7,762,802 which is tremendous compared to the last 3 months average volume of 247,865.
Hypersolar Inc. today announced that it has jointly filed a patent application with the University of California, Santa Barbara (“UCSB”) for the “protection and stability of electroactive units used for production of fuels and chemicals.”
Find out if HYSR could maintain its bullish momentum by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=HYSR
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetBarron.com website, for complete risks and disclosures.
WALL STREET REPORT